Affiliations 

  • 1 Arthroscopy and Sports Injury Unit, Department of Orthopaedic and Traumatology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
  • 2 Centre for Shoulder and Elbow Surgery, ATOS Clinic Munich, Munich, Germany
  • 3 Centre for Shoulder and Elbow Surgery, ATOS Clinic Munich, Munich, Germany. f.martetschlaeger@gmail.com
Knee Surg Sports Traumatol Arthrosc, 2019 Dec;27(12):3797-3802.
PMID: 30900030 DOI: 10.1007/s00167-019-05482-7

Abstract

PURPOSE: Arthroscopic-assisted stabilization surgery for acute acromioclavicular joint (ACJ) disruption shows excellent and reliable clinical outcomes. However, characteristic complications such as fracture of the clavicle and coracoid have been reported to occur during the early post-operative period. The main goal of this study was to highlight the occurrence of fractures as a late post-operative complication. The secondary goals were to describe possible fracture morphologies and treatment outcomes.

METHOD: Patient records from a single surgery centre were searched for all patients presenting with late fracture complication following arthroscopically assisted acromioclavicular stabilization. Medical reports including the operative notes and pre- and post-operative X-rays were reviewed. A telephone interview was conducted with each patient to access the American Shoulder and Elbow Surgeons shoulder score.

RESULTS: A total of four patients presented with late fracture complication following arthroscopic-assisted ACJ stabilization surgery. All patients were males and presented following trauma at a median duration of 19.5 months after the index surgery. Fracture morphology differed between patients; the treatment was conservative in three patients, while one patient underwent osteosynthesis.

CONCLUSION: Traumatic peri-implant fractures can occur, even 2 years after arthroscopically assisted ACJ reconstruction. This needs to be considered when planning for surgical intervention in acute ACJ disruption, especially in a high-risk population.

LEVEL OF EVIDENCE: Therapeutic study, Level IV.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.